December 07, 2022

Cryptolepsis 1:2 (Cryptolepis Sanguinolenta)

Description:

Cryptolepsis is a potent antimicrobial against resistant systemic infections both Gram-positive and Gram-negative, mycobacterial infections and some fungal infections

Dosage:

30-100 mls per day, 4-14 mls per week

Parts Used:

Root

Main Actions:

  • Antiamoebic
  • Antibacterial
  • Anticancer
  • Anticomplement
  • Antifungal
  • Antihyperglycaemic
  • Anti-inflammatory
  • Antimycobacterial
  • Antiparasitic
  • Antiplasmodial
  • Antipyretic
  • Antiviral (mild)
  • Hypothermic

Key Indications:

Bacterial infections

Gram-positive bacteria:

Bacillus cereus, Bacillus subtilis, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus saprophyticus, Streptococcus pyogenes

Gram-negative bacteria:

Campylobacter coli, Campylobacter jejuni, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Neisseria gonorrhoeae, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella typhi, Salmonella typhimurium, Shigella dysenteriae, Vibrio cholera

Mycobacteria:

Mycobacterium abcessus, Mycobacterium aurum, Mycobacterium bovis

BCG, Mycobacterium fortuitum, Mycobacterium phlei, Mycobacterium smegmatis, Mycobacterium tuberculosis

(including drug resistant strains)

  • Cancer treatment adjunct
  • Diabetes
  • Fever

Fungal infections :

  • Aspergillus niger, Candida albicans*, Microsporum canis, Epidermophyton floccosum*, Saccharomyces cerevisiae, Trichophyton rubrum*, Trichophyton mentagrophytes
  • Malaria
  • Neurodegenerative conditions

Parasitic infections :

  • Babesia species, Entamoeba histolytica, Plasmodium falciparum
  • (including chloroquine-resistant
  • Systemic infections
  • Urinary tract infections (UTIs)
  • Viral infections
  • Herpes simplex virus (HSV)

Major Safety Issues:

None known